| Global epidemiology of lung cancer JA Barta, CA Powell, JP Wisnivesky Annals of global health 85 (1), 2019 | 1502 | 2019 |
| Black patients referred to a lung cancer screening program experience lower rates of screening and longer time to follow-up M Lake, CS Shusted, HS Juon, RK McIntire, C Zeigler-Johnson, ... BMC cancer 20, 1-12, 2020 | 87 | 2020 |
| Lipid synthesis is required to resolve endoplasmic reticulum stress and limit fibrotic responses in the lung F Romero, X Hong, D Shah, CB Kallen, I Rosas, Z Guo, DL Schriner, ... American journal of respiratory cell and molecular biology 59 (2), 225-236, 2018 | 67 | 2018 |
| The case for patient navigation in lung cancer screening in vulnerable populations: a systematic review CS Shusted, JA Barta, M Lake, R Brawer, B Ruane, TE Giamboy, ... Population Health Management 22 (4), 347-361, 2019 | 56 | 2019 |
| Lung cancer in the older patient JA Barta, RG Zinner, M Unger Clinics in geriatric medicine 33 (4), 563-577, 2017 | 35 | 2017 |
| Lung cancer diagnosis by fine needle aspiration is associated with reduction in resection of nonmalignant lung nodules JA Barta, CI Henschke, RM Flores, R Yip, DF Yankelevitz, CA Powell The Annals of thoracic surgery 103 (6), 1795-1801, 2017 | 33 | 2017 |
| Racial disparities in occupational risks and lung cancer incidence: analysis of the National Lung Screening Trial HS Juon, A Hong, M Pimpinelli, M Rojulpote, R McIntire, JA Barta Preventive Medicine 143, 106355, 2021 | 24 | 2021 |
| Racial differences in lung cancer screening beliefs and screening adherence JA Barta, CS Shusted, B Ruane, M Pimpinelli, RK McIntire, ... Clinical lung cancer 22 (6), 570-578, 2021 | 21 | 2021 |
| Lung-enriched mutations in the p53 tumor suppressor: a paradigm for tissue-specific gain of oncogenic function JA Barta, SB McMahon Molecular Cancer Research 17 (1), 3-9, 2019 | 20 | 2019 |
| Association of race with lung cancer risk among adults undergoing lung cancer screening CS Shusted, NR Evans, HS Juon, GC Kane, JA Barta JAMA Network Open 4 (4), e214509-e214509, 2021 | 19 | 2021 |
| The lung-enriched p53 mutants V157F and R158L/P regulate a gain of function transcriptome in lung cancer JA Barta, K Pauley, AV Kossenkov, SB McMahon Carcinogenesis 41 (1), 67-77, 2020 | 17 | 2020 |
| Analysis of lung cancer screening by race after USPSTF expansion of screening eligibility in 2021 CS Shusted, NR Evans, GC Kane, HS Juon, JA Barta JAMA Network Open 5 (6), e2217578-e2217578, 2022 | 16 | 2022 |
| Outreach to primary care patients in lung cancer screening: a randomized controlled trial M DiCarlo, P Myers, C Daskalakis, A Shimada, S Hegarty, ... Preventive Medicine 159, 107069, 2022 | 12 | 2022 |
| Characterizing pulmonary function test changes for patients with lung cancer treated on a 2-institution, 4-dimensional computed tomography-ventilation functional avoidance … R Miller, R Castillo, E Castillo, BL Jones, M Miften, B Kavanagh, B Lu, ... Advances in Radiation Oncology 8 (2), 101133, 2023 | 8 | 2023 |
| Detection of lung carcinoma arising from ground glass opacities (GGO) after 5 years-A retrospective review E Herskovitz, C Solomides, J Barta, N Evans III, G Kane Respiratory medicine 196, 106803, 2022 | 8 | 2022 |
| The Philadelphia Lung Cancer Learning Community: a multi–health-system, citywide approach to lung cancer screening JA Barta, CP Erkmen, CS Shusted, RE Myers, C Saia, S Cohen, ... JNCI cancer spectrum 7 (5), pkad071, 2023 | 6 | 2023 |
| Frequency of statin prescription among individuals with coronary artery calcifications detected through lung cancer screening A Majeed, B Ruane, CS Shusted, M Austin, K Mirzozoda, M Pimpinelli, ... American journal of medical quality 37 (5), 388-395, 2022 | 6 | 2022 |
| Racial difference in BMI and lung cancer diagnosis: analysis of the National Lung Screening Trial J Zhao, JA Barta, R McIntire, C Shusted, C Zeigler-Johnson, HS Juon BMC cancer 22 (1), 797, 2022 | 6 | 2022 |
| Race is a risk factor for the deferral of resection and radiation for early-stage lung cancer CY Huang, S Mack, TR Grenda, JA Barta, BM Till, NR Evans, O Okusanya Clinical Lung Cancer 23 (7), e460-e472, 2022 | 5 | 2022 |
| Now is the time to make screening for lung cancer reportable GC Kane, JA Barta, CS Shusted, NR Evans Annals of Internal Medicine 175 (6), 888-889, 2022 | 5 | 2022 |
